– Evert (Eef) Schimmelpennink, experienced biopharmaceutical leader with significant track record of success in R&D and commercialization, joins as President and CEO – SAN DIEGO--(BUSINESS WIRE)--LENZ ...
SAN DIEGO & SHANGHAI & NEW YORK--(BUSINESS WIRE)--LENZ Therapeutics (LENZ), a biopharmaceutical company with a lead late clinical-stage program that represents a potential best-in-class therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results